Health News People 50 And Older Should Get Pneumococcal Vaccine, U S Health Officials Recommend
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Health News People 50 And Older Should Get Pneumococcal Vaccine, U S Health Officials Recommend is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Study provides more positive data on adult pneumococcal vaccine
Findings from a phase 3 study provided additional evidence that the first pneumococcal vaccine made specifically for adults is well tolerated and provides strong protection for patients at an ... Read More
Six vaccines that can keep you safe this holiday season
Stay healthy this holiday season by getting vaccinated against COVID-19, flu, RSV, and other viruses. Consult a healthcare professional for guidance. Read More
It's Not Too Late to Get Vaccinated This Respiratory Season
In a time of confusion and inconsistent information, healthcare professionals want you to know that it’s not too late to get vaccinated this respiratory season. Getting vaccinated helps protect ... Read More
Pfizer’s Latest Study on 20-Valent Pneumococcal Vaccine: What Investors Need to Know
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ... Read More
As vaccines industry struggles, Merck's adult pneumococcal shot Capvaxive off to strong start
With vaccine sales on the decline across the industry, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. But in the third quarter, the company recorded encouraging sales ... Read More
GSK’s AFX3772 Vaccine Study: A New Contender in Infant Pneumococcal Prevention
GlaxoSmithKline ((GSK)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus